Evotec invests €15m to further AI-driven drug discovery
Evotec AG has acquired a minority stake in Exscientia – a company focused on artificial intelligence (AI)-driven drug discovery and design.
Archives for October 4, 2017
Add to cart: Online marketplaces join forces to provide researchers instant access to biospecimens
To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.
Ignoring misconceptions of clinical research vs. clinical care ‘devalues participants’ dignity’
Clinical trial participants often misunderstand the differences between research and clinical care – a ‘longstanding problem’ that an enhanced informed consent process could diminish, says report.
Merck KGaA to spend €35m to replace filling line at Bari facility
Merck KGaA will install a new aseptic filling line at its facility in Bari, Italy for multiple sclerosis drugs, fertility treatments and growth hormones.
Titan tests implant tech to curb opioid overdose
Titan has teamed with Opiant to investigate skin implant technology in the administration of opioid antagonists over extended periods, to combat opioid relapse and overdose in outpatients.
French police visit Merck KGaA Lyon plant as part of levothyrox probe
Police investigating thousands of adverse events linked to Levothyrox, a reformulated version of the hypothyroidism pill Euthyrox, have visited Merck KGaA's production facility in Lyon, France.
Biotech Week Boston
Shire: Getting smart with delivery tech key in developing orphan drugs
Rare disease therapies need to be administered in a way that suit the patient according to Shire CEO Flemming Ørnskov, who says smart, flexible delivery devices are core to the firm's product development strategy.